ISSN 2149-2263 | E-ISSN 2149-2271 Home      
Volume : 24 Issue : 2
Current Issue Archive Popular Article Ahead of Print

Precision medicine: The future of diagnostic approach to pulmonary hypertension? [Anatol J Cardiol]
Anatol J Cardiol. 2019; 22(4): 168-171 | DOI: 10.14744/AnatolJCardiol.2019.97820  

Precision medicine: The future of diagnostic approach to pulmonary hypertension?

Piotr Kedzierski, Adam Torbicki
Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Center-Otwock, Member of ERN-LUNG; Otwock-Poland

Pulmonary hypertension (PH) is a common finding that can result from many different pathological conditions. Depending on the etiology, treatment may be quite different, but early diagnosis and correct classification of PH is difficult. With an aging population and recently suggested decreased pulmonary arterial pressure threshold defining PH, we are facing even more diagnostic uncertainties. A new approach to patients’ phenotyping is needed. Here we present available data and future perspectives on employing an in-depth analysis of the omics cascade to allow an earlier and more reliable diagnosis and classification of PH. Indeed, with the help of super-fast computing, it became possible to simultaneously consider the levels of thousands of potential biomarkers to find patterns specific for clinically suspected disease. The omics cascade is an invaluable source of information. However, while the genome can be perceived as providing possibilities, transcriptome–as carving them this is metabolome that may tell us “what is really going on” in an individual living organism. Metabolomics research requires blinded search for characteristic patterns of discreet changes in the levels of detectable metabolites. Since as many as 40,000 various substances are produced as a “side effect of staying alive”, metabolite profiling can be compared to fishing up for organized signals in a universe of chaos. Although difficult, such search for metabolic patterns that might lead to replacing the term biomarker by metabolic fingerprinting in the area of pulmonary circulation has already begun.

Keywords: Pulmonary hypertension, systems biology, metabolome, genome, transcriptome, proteome, epigenetics.

Piotr Kedzierski, Adam Torbicki. Precision medicine: The future of diagnostic approach to pulmonary hypertension?. Anatol J Cardiol. 2019; 22(4): 168-171

Corresponding Author: Adam Torbicki, Poland

Full Text PDF
Download citation
Reference Manager
Share with email
Send email to author

Similar articles
Google Scholar

KARE Publishing | Copyright © 2019 Turkish Society of Cardiology